Published in J Am Coll Cardiol on October 06, 2011
Implementation of a pilot accountable care organization payment model and the use of discretionary and nondiscretionary cardiovascular care. Circulation (2014) 1.56
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J (2014) 1.55
Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities). JACC Heart Fail (2014) 1.46
Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database. Circulation (2014) 1.44
TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial. Trials (2015) 1.41
The Diagnosis and Treatment of Peripheral Arterial Vascular Disease. Dtsch Arztebl Int (2016) 1.33
Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol (2012) 1.04
Automated photoplethysmography-based determination of ankle-brachial index: a validation study against Doppler sonography. Clin Res Cardiol (2012) 0.96
The place of endovascular treatment in abdominal aortic aneurysm. Dtsch Arztebl Int (2013) 0.96
Angiogenic factor AGGF1 promotes therapeutic angiogenesis in a mouse limb ischemia model. PLoS One (2012) 0.89
Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study. Pan Afr Med J (2014) 0.87
Prospective relationship of low cardiovascular risk factor profile at younger ages to ankle-brachial index: 39-year follow-up--the Chicago Healthy Aging Study. J Am Heart Assoc (2012) 0.86
Renal artery stenosis predicts coronary artery disease in patients with hypertension. PLoS One (2013) 0.86
Pulse pressure and subclinical peripheral artery disease. J Hum Hypertens (2013) 0.85
Therapeutic angiogenesis in critical limb ischemia. Angiology (2012) 0.85
Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol (2015) 0.85
Relation between the ankle-brachial index and the complexity of coronary artery disease in older patients. Clin Interv Aging (2013) 0.84
Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes. Adv Chronic Kidney Dis (2014) 0.84
Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease. J Vasc Surg (2013) 0.84
Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions. Circ Cardiovasc Imaging (2012) 0.83
Peripheral arterial disease and chronic heart failure: a dangerous mix. Heart Fail Rev (2013) 0.83
Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease. J Am Heart Assoc (2016) 0.82
Stroke patients with a past history of cancer are at increased risk of recurrent stroke and cardiovascular mortality. PLoS One (2014) 0.82
In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia. J Vasc Surg (2013) 0.82
Effect of premeasurement rest time on systolic ankle pressure. J Am Heart Assoc (2013) 0.82
Physiology in medicine: peripheral arterial disease. J Appl Physiol (1985) (2013) 0.81
Ankle/brachial index to everyone. BMC Surg (2012) 0.80
Vascular assessment techniques of podiatrists in Australia and New Zealand: a web-based survey. J Foot Ankle Res (2015) 0.80
Use of hand-held Doppler ultrasound examination by podiatrists: a reliability study. J Foot Ankle Res (2015) 0.80
Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence. Vasc Health Risk Manag (2015) 0.79
Automated plethysmographic measurement of the ankle-brachial index: a comparison with the doppler ultrasound method. Hypertens Res (2015) 0.79
Screen or not to screen for peripheral arterial disease: guidance from a decision model. BMC Public Health (2014) 0.79
Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial. J Am Heart Assoc (2016) 0.79
Prevalence of lower extremity peripheral artery disease among adult diabetes patients in southwestern Uganda. BMC Cardiovasc Disord (2014) 0.78
Renovascular hypertension: is there still a role for stent revascularization? Curr Opin Nephrol Hypertens (2013) 0.78
Clinical utility of transthoracic echocardiography for screening abdominal aortic aneurysm: a prospective study in a Japanese population. Cardiovasc Ultrasound (2016) 0.78
Ankle-brachial index and physical function in older individuals: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis (2016) 0.77
Association between the ankle-brachial index, intermittent claudication, and physical activity level: what is the influence on the functional capacity of patients with or at high risk of cardiovascular disease? Int J Gen Med (2015) 0.77
Cyclophilin A is associated with peripheral artery disease and chronic kidney disease in geriatrics: The Tianliao Old People (TOP) study. Sci Rep (2015) 0.77
β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease. J Am Heart Assoc (2014) 0.77
Outcomes and characteristics of patients undergoing percutaneous angioplasty followed by below-knee or above-knee amputation for peripheral artery disease. PLoS One (2014) 0.77
Fourth Asian PAD Workshop. Ann Vasc Dis (2013) 0.77
Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Am Heart J (2012) 0.77
Femoropopliteal Artery Stent Thrombosis: Report From the Excellence in Peripheral Artery Disease Registry. Circ Cardiovasc Interv (2016) 0.77
Association of depressive symptoms, trait anxiety, and perceived stress with subclinical atherosclerosis: results from the Chicago Healthy Aging Study (CHAS). Prev Med (2014) 0.76
Comparisons of different metabolic syndrome definitions and associations with coronary heart disease, stroke, and peripheral arterial disease in a rural Chinese population. PLoS One (2015) 0.76
Stent revascularization versus bypass surgery for peripheral artery disease in type 2 diabetic patients - an instrumental variable analysis. Sci Rep (2016) 0.75
Clopidogrel for Atherothrombotic Event Management in Patients with Peripheral Arterial Disease (COOPER) Study: Safety and Efficacy of Clopidogrel versus Ticlopidine in Japanese Patients. Ann Vasc Dis (2012) 0.75
Aspirin Resistance Predicts Adverse Cardiovascular Events in Patients with Symptomatic Peripheral Artery Disease. Tex Heart Inst J (2016) 0.75
Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial. Trials (2017) 0.75
Evaluation of peripheral arterial disease in prediabetes. Int J Prev Med (2014) 0.75
RX Herculink Elite(®) renal stent system: a review of its use for the treatment of renal artery stenosis. Med Devices (Auckl) (2012) 0.75
Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study. Biomed Res Int (2016) 0.75
Effects of percutaneous lower-extremity arterial interventions on endothelial function and inflammation response in patients with both type 2 diabetes and lower-extremity peripheral arterial disease. Int J Clin Exp Pathol (2015) 0.75
Usefulness of the platelet-to-lymphocyte ratio in predicting long-term cardiovascular mortality in patients with peripheral arterial occlusive disease. Postepy Kardiol Interwencyjnej (2017) 0.75
Novel magnetic resonance imaging end points for physiologic studies in peripheral arterial disease: elegance versus practicality. Circ Cardiovasc Imaging (2015) 0.75
Abdominal aortic aneurysm presenting as a claudication. Korean J Spine (2013) 0.75
Association between functional performance and executive cognitive functions in an elderly population including patients with low ankle-brachial index. Clin Interv Aging (2015) 0.75
Relationship between percentage of mean arterial pressure at the ankle and mortality in participants with normal ankle-brachial index: an observational study. BMJ Open (2016) 0.75
Lower extremity amputation in peripheral artery disease: improving patient outcomes. Vasc Health Risk Manag (2014) 0.75
A predictable propensity: secondary revascularization is associated with further revascularization. J Am Heart Assoc (2013) 0.75
Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization. J Vasc Surg (2016) 0.75
Distribution of Ankle-Brachial Index among Inpatients with Cardiovascular Disease: Analysis Using the Kumamoto University Hospital Medical Database. Ann Vasc Dis (2016) 0.75
Detection of peripheral arterial disease with an improved automated device: comparison of a new oscillometric device and the standard Doppler method. Vasc Health Risk Manag (2016) 0.75
Very Low Frequency of PAD in People with CHD in Six Middle Eastern Countries. Int J Vasc Med (2012) 0.75
Preoperative Cardiac Evaluation and Management of the Patient Undergoing Major Vascular Surgery. Int Anesthesiol Clin (2016) 0.75
Pulse Pressure and Upstroke Time Are Useful Parameters for the Diagnosis of Peripheral Artery Disease in Patients With Normal Ankle Brachial Index. Cardiol Res (2016) 0.75
Therapeutic efficacy of apelin on transplanted mesenchymal stem cells in hindlimb ischemic mice via regulation of autophagy. Sci Rep (2016) 0.75
Associations between the toe brachial index and health-related quality of life in older people. Health Qual Life Outcomes (2016) 0.75
Disruption of mitochondrial quality control in peripheral artery disease: New therapeutic opportunities. Pharmacol Res (2016) 0.75
Long-Term Prognostic Risk in Lower Extremity Peripheral Arterial Disease as a Function of the Number of Peripheral Arterial Lesions. J Am Heart Assoc (2015) 0.75
Resting and Post-Exercise Ankle-Brachial Index Measurements to Diagnose Asymptomatic Peripheral Arterial Disease in Middle Aged and Elderly Chronic Obstructive Pulmonary Disease Patients: A Pilot Study. J Clin Med Res (2016) 0.75
Intracranial hemorrhage and platelet transfusion after administration of anti-platelets agents: Fukushima Prefecture. Fukushima J Med Sci (2016) 0.75
Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease. Vasc Health Risk Manag (2014) 0.75
Recent publications by ochsner authors. Ochsner J (2012) 0.75
Clinical Characteristics and Outcomes of Patients with High Ankle-Brachial Index from the IMPACT-ABI Study. PLoS One (2016) 0.75
The impact of inflow treatment for claudicants with both aortoiliac and femoropopliteal occlusive disease. Surg Today (2016) 0.75
Validity and reliability of the ankle-brachial index by oscillometric blood pressure and automated ankle-brachial index. J Res Med Sci (2017) 0.75
Premature Valvular Heart Disease in Homozygous Familial Hypercholesterolemia. Cholesterol (2017) 0.75
Cardiovascular risk in patients with alpha-1-antitrypsin deficiency. Respir Res (2017) 0.75
Endovascular treatment of infrapopliteal arteries: angioplasty vs stent in the drug-eluting era. Eur Radiol (2014) 0.75
Lower Extremity Peripheral Artery Disease and Quality of Life Among Older Individuals in the Community. J Am Heart Assoc (2017) 0.75
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet (1996) 16.32
Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA (2001) 13.65
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg (2006) 10.79
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med (1999) 10.62
Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med (2009) 10.60
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med (2010) 7.83
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet (2005) 7.25
Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA (2009) 6.11
Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA (2009) 5.66
Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA (2010) 5.10
Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med (2005) 5.02
An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med (1995) 4.08
Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med (2007) 3.74
Long-term outcome of open or endovascular repair of abdominal aortic aneurysm. N Engl J Med (2010) 3.70
High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis (2004) 3.55
Thromboangiitis obliterans (Buerger's disease). N Engl J Med (2000) 3.46
Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg (2006) 3.38
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Arch Intern Med (2006) 3.30
Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation (2009) 3.28
Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest (2007) 2.90
The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med (1996) 2.85
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg (2008) 2.55
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J (2006) 1.98
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology (Berl) (2007) 1.92
Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med (2010) 1.92
Predictors of initial smoking cessation and relapse through the first 2 years of the Lung Health Study. J Consult Clin Psychol (1995) 1.86
Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J (2009) 1.80
Revascularisation of renal artery stenosis caused by fibromuscular dysplasia: effects on blood pressure during 7-year follow-up are influenced by duration of hypertension and branch artery stenosis. J Hum Hypertens (2005) 1.79
The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol (1988) 1.75
Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial. J Am Coll Cardiol (2010) 1.59
Clinical measurement of systolic pressures in limbs with arterial occlusive disease. JAMA (1969) 1.44
Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am J Epidemiol (1994) 1.41
TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? Diabet Med (2001) 1.34
Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. J Intern Med (2007) 1.13
Effect on cessation counseling of documenting smoking status as a routine vital sign: an ACORN study. Ann Fam Med (2008) 1.11
Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand (1987) 1.07
The UK Endovascular Aneurysm Repair (EVAR) trials: design, methodology and progress. Eur J Vasc Endovasc Surg (2004) 1.06
The measured effect of stopping smoking on intermittent claudication. Br J Surg (1982) 1.04
The effect of cigarette smoking on exercise capacity in patients with intermittent claudication. Vasc Med (1996) 0.96
The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease. Med J Aust (1983) 0.95
A reassessment of Doppler pressure indices in the detection of arterial lesions in proximity penetrating injuries of extremities: a prospective study. Am J Emerg Med (1996) 0.92
Mecamylamine (a nicotine antagonist) for smoking cessation. Cochrane Database Syst Rev (2000) 0.92
Toe blood pressure. A valuable adjunct to ankle pressure measurement for assessing peripheral arterial disease. J Cardiovasc Surg (Torino) (1983) 0.91
Value of toe pulse waves in addition to systolic pressures in the assessment of the severity of peripheral arterial disease and critical limb ischemia. J Vasc Surg (1996) 0.91
The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model. Value Health (2009) 0.90
Reproducibility of noninvasive vascular laboratory measurements of the peripheral circulation. J Vasc Surg (1987) 0.88
Operative mortality for renal artery bypass in the United States: Results from the National Inpatient Sample. J Vasc Surg (2008) 0.86
Segmental measurements of systolic blood pressure in the extremities including the thumb and the great toe. Acta Chir Scand Suppl (1972) 0.83
The value of toe pulse waves in determination of risks for limb amputation and death in patients with peripheral arterial disease and skin ulcers or gangrene. J Vasc Surg (2001) 0.82
Cigarette smoking and the outcome after lower limb arterial surgery. Acta Chir Scand (1989) 0.81
Toe pulse reappearance time in prediction of aortofemoral bypass success. Ann Surg (1981) 0.80
The value of segmental pressure measurement in the assessment of peripheral vascular disease. Int Angiol (1986) 0.79
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med (2004) 12.58
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2013) 7.70
Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA (2011) 7.61
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med (2002) 7.35
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol (2011) 6.35
One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61
Efficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med (2015) 5.36
Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation (2006) 5.31
Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation (2012) 5.25
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation (2011) 5.16
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA (2006) 5.00
Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation (2003) 4.61
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery. J Am Coll Cardiol (2013) 4.46
Fibromuscular dysplasia. N Engl J Med (2004) 4.45
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 4.01
Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med (2009) 3.73
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. N Engl J Med (2015) 3.69
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59